617 related articles for article (PubMed ID: 30182330)
1. Aberrant miRNAs Regulate the Biological Hallmarks of Glioblastoma.
Yu W; Liang S; Zhang C
Neuromolecular Med; 2018 Dec; 20(4):452-474. PubMed ID: 30182330
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of MicroRNAs in patients with glioblastoma after concomitant chemoradiotherapy.
Park EC; Kim G; Jung J; Wang K; Lee S; Jeon SS; Lee ZW; Kim SI; Kim S; Oh YT; Shin JH; Jang HS; Choi BO; Kim GH
OMICS; 2013 May; 17(5):259-68. PubMed ID: 23586679
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA regulating stanniocalcin-1 is a metastasis and dissemination promoting factor in glioblastoma.
Sakata J; Sasayama T; Tanaka K; Nagashima H; Nakada M; Tanaka H; Hashimoto N; Kagawa N; Kinoshita M; Nakamizo S; Maeyama M; Nishihara M; Hosoda K; Kohmura E
J Neurooncol; 2019 Apr; 142(2):241-251. PubMed ID: 30701354
[TBL] [Abstract][Full Text] [Related]
4. MiR-203 downregulation is responsible for chemoresistance in human glioblastoma by promoting epithelial-mesenchymal transition via SNAI2.
Liao H; Bai Y; Qiu S; Zheng L; Huang L; Liu T; Wang X; Liu Y; Xu N; Yan X; Guo H
Oncotarget; 2015 Apr; 6(11):8914-28. PubMed ID: 25871397
[TBL] [Abstract][Full Text] [Related]
5. MiR-338-5p sensitizes glioblastoma cells to radiation through regulation of genes involved in DNA damage response.
Besse A; Sana J; Lakomy R; Kren L; Fadrus P; Smrcka M; Hermanova M; Jancalek R; Reguli S; Lipina R; Svoboda M; Slampa P; Slaby O
Tumour Biol; 2016 Jun; 37(6):7719-27. PubMed ID: 26692101
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA‑543 inhibits proliferation, invasion and induces apoptosis of glioblastoma cells by directly targeting ADAM9.
Ji T; Zhang X; Li W
Mol Med Rep; 2017 Nov; 16(5):6419-6427. PubMed ID: 28849046
[TBL] [Abstract][Full Text] [Related]
7. miR128-1 inhibits the growth of glioblastoma multiforme and glioma stem-like cells via targeting BMI1 and E2F3.
Shan ZN; Tian R; Zhang M; Gui ZH; Wu J; Ding M; Zhou XF; He J
Oncotarget; 2016 Nov; 7(48):78813-78826. PubMed ID: 27705931
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs involved in the EGFR pathway in glioblastoma.
Xu B; Mei J; Ji W; Huo Z; Bian Z; Jiao J; Li X; Sun J; Shao J
Biomed Pharmacother; 2021 Feb; 134():111115. PubMed ID: 33341046
[TBL] [Abstract][Full Text] [Related]
9. The emerging role of tumor-suppressive microRNA-218 in targeting glioblastoma stemness.
Gao X; Jin W
Cancer Lett; 2014 Oct; 353(1):25-31. PubMed ID: 25042866
[TBL] [Abstract][Full Text] [Related]
10. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of PDGFRB and EGFR in microvascular proliferation in glioblastoma.
Xu G; Li JY
Tumour Biol; 2016 Aug; 37(8):10577-86. PubMed ID: 26857280
[TBL] [Abstract][Full Text] [Related]
12. miRNAs role in glioblastoma pathogenesis and targeted therapy: Signaling pathways interplay.
Elshaer SS; Abulsoud AI; Fathi D; Abdelmaksoud NM; Zaki MB; El-Mahdy HA; Ismail A; Elsakka EGE; Abd-Elmawla MA; Abulsoud LA; Doghish AS
Pathol Res Pract; 2023 Jun; 246():154511. PubMed ID: 37178618
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA‑518b functions as a tumor suppressor in glioblastoma by targeting PDGFRB.
Xu X; Zhang F; Chen X; Ying Q
Mol Med Rep; 2017 Oct; 16(4):5326-5332. PubMed ID: 28849154
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA expression signatures and their correlation with clinicopathological features in glioblastoma multiforme.
Henriksen M; Johnsen KB; Olesen P; Pilgaard L; Duroux M
Neuromolecular Med; 2014 Sep; 16(3):565-77. PubMed ID: 24817689
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of long non-coding RNA XIST exerts tumor-suppressive functions in human glioblastoma stem cells by up-regulating miR-152.
Yao Y; Ma J; Xue Y; Wang P; Li Z; Liu J; Chen L; Xi Z; Teng H; Wang Z; Li Z; Liu Y
Cancer Lett; 2015 Apr; 359(1):75-86. PubMed ID: 25578780
[TBL] [Abstract][Full Text] [Related]
16. miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal.
Lulli V; Buccarelli M; Martini M; Signore M; Biffoni M; Giannetti S; Morgante L; Marziali G; Ilari R; Pagliuca A; Larocca LM; De Maria R; Pallini R; Ricci-Vitiani L
Oncotarget; 2015 Nov; 6(35):37241-56. PubMed ID: 26437223
[TBL] [Abstract][Full Text] [Related]
17. LGR5 promotes tumorigenicity and invasion of glioblastoma stem-like cells and is a potential therapeutic target for a subset of glioblastoma patients.
Xie Y; Sundström A; Maturi NP; Tan EJ; Marinescu VD; Jarvius M; Tirfing M; Jin C; Chen L; Essand M; Swartling FJ; Nelander S; Jiang Y; Uhrbom L
J Pathol; 2019 Feb; 247(2):228-240. PubMed ID: 30357839
[TBL] [Abstract][Full Text] [Related]
18. Targeting strategies on miRNA-21 and PDCD4 for glioblastoma.
Wang G; Wang JJ; Tang HM; To SS
Arch Biochem Biophys; 2015 Aug; 580():64-74. PubMed ID: 26142886
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs: a complex regulatory network drives the acquisition of malignant cell phenotype.
Santarpia L; Nicoloso M; Calin GA
Endocr Relat Cancer; 2010 Mar; 17(1):F51-75. PubMed ID: 19843580
[TBL] [Abstract][Full Text] [Related]
20. MiR-21: A key player in glioblastoma pathogenesis.
Masoudi MS; Mehrabian E; Mirzaei H
J Cell Biochem; 2018 Feb; 119(2):1285-1290. PubMed ID: 28727188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
